U.S., April 30 -- ClinicalTrials.gov registry received information related to the study (NCT07556523) titled 'Patient Quality of Recovery After TAVR With Different Sedation Regimens' on April 15.
Brief Summary: The goal of this clinical trial is to learn whether the type of sedation medication used during a transcatheter aortic valve replacement (TAVR) affects how people recover after the procedure. The main question this study aims to answer is whether different sedation regimens (propofol, dexmedetomidine, or midazolam with fentanyl) lead to differences in quality of recovery on the first day after the procedure.
Researchers will compare three commonly used sedation medications (propofol, dexmedetomidine, or midazolam with fentanyl) to ...